Home News & Events ICON survey highlights scale of focus on precision therapies in increasingly complex oncology landscape Read the press release ICON recognised for leadership in clinical research and as socially responsible employer Read the press release New ICON survey highlights importance of combination therapies in future obesity treatment Read the press release Press releases 27 September 2024 ICON plc Schedules Third Quarter 2024 Earnings Conference Call 12 September 2024 ICON survey highlights scale of focus on precision therapies in increasingly complex oncology landscape 03 September 2024 ICON plc to present at the Baird 2024 Global Healthcare Conference 14 August 2024 ICON Announces appointment of new Chief Financial Officer (CFO) 24 July 2024 ICON Reports Second Quarter 2024 Results 24 July 2024 ICON announces results of Annual General Meeting and changes to the Board of Directors 10 July 2024 ICON recognised for leadership position in clinical research industry and as socially responsible employer 01 July 2024 ICON plc schedules second quarter 2024 earnings conference call 04 June 2024 ICON plc to Present at the Jefferies Global Healthcare Conference Events 15 October 2024 FDA guidance on use of Data Monitoring Committees in Clinical Trials 16 October 2024 - 17 October 2024 IRT 2024 22 October 2024 - 25 October 2024 World Orphan Drug Congress Europe 23 October 2024 - 24 October 2024 OCT New England 24 October 2024 Dosimetry in clinical trials 28 October 2024 - 31 October 2024 World Vaccine Congress Europe 28 October 2024 - 29 October 2024 Longwood Healthcare Leaders Boston 29 October 2024 - 30 October 2024 World Drug Safety Congress 15 November 2024 Unlocking global strategies with proactive regulatory translation management Awards ICON Press office enquiries Videos Media articles What’s happening in ICON